Insmed Inc. Stock
Price
Target price
€50.50
€50.50
3.060%
1.5
3.060%
€52.40
31.05.24 / Stuttgart Stock Exchange
WKN: A1JJA3 / Symbol: INSM / Name: Insmed / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Insmed Inc. Stock
A very strong showing by Insmed Inc. today, with an increase of €1.50 (3.060%) compared to yesterday's price.
The stock is one of the favorites of our community with 28 Buy predictions and 2 Sell predictions.
With a target price of 52 € there is a slightly positive potential of 2.97% for Insmed Inc. compared to the current price of 50.5 €.
So far the community has only identified positive things for Insmed Inc. stock. The most positive votes were given for criterium "Worthwhile Investment for the next years".
Pros and Cons of Insmed Inc. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Insmed Inc. vs. its peers
Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Insmed Inc. | 3.060% | 138.208% | 112.185% | 182.123% | 76.573% | 142.788% | 128.714% |
Evolus Inc | 2.610% | 2.609% | 0.000% | 44.785% | 30.387% | 26.203% | - |
Ardelyx Inc. | 3.070% | 1.608% | 0.032% | 93.211% | 9.308% | 11.823% | - |
Salarius Pharmaceuticals Inc. | - | -3.015% | -16.087% | -67.833% | -30.450% | -98.515% | -99.994% |
Comments
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at Stifel Nicolaus from $39.00 to $67.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at TD Cowen from $45.00 to $67.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat
Insmed Incorporated (NASDAQ: INSM) had its price target raised by analysts at UBS Group AG from $46.00 to $58.00. They now have a "buy" rating on the stock.
Show more
Ratings data for INSM provided by MarketBeat